Search Results

Press Releases

GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting

November 7, 2024

·

3 min read

BioMidwest

GenomOncology Introduces Expanded Support for Germline Testing in GO Pathology Workbench

GenomOncology revealed an upgraded version of GO Pathology Workbench, their software platform for tertiary analysis and reporting of next generation sequencing and other molecular testing results.

April 29, 2024

·

2 min read

Press Releases

GenomOncology Partners with Precipio to Advance Myeloid Testing and Reporting

September 11, 2024

·

3 min read

BioMidwest

GenomOncology Welcomes Garreth Hippe as Chief Commercial Officer

GenomOncology, a prominent precision oncology software company, announced the appointment of Garreth Hippe as Chief Commercial Officer.

October 3, 2023

·

2 min read

BioMidwest

GenomOncology Selected by Personalis to Support MRD and SNV Analysis for NeXT Personal™ Assay

GenomOncology announced that the GenomOncology Pathology Workbench has been selected by Personalis to support its NeXT Personal assay for molecular residual disease detection.

July 12, 2022

·

2 min read

Business

GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution

Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.

August 4, 2022

·

3 min read

BioMidwest

GenomOncology Boosts Treatment Matching Capabilities with Integration of Prior Intervention Eligibility Criteria

GenomOncology announced that their Precision Oncology Platform now integrates patients’ prior intervention eligibility criteria to further advance their treatment matching algorithm and decision support capabilities.

June 16, 2022

·

3 min read

BioMidwest

GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors

GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp’s OmniSeq to support the analysis and reporting of OmniSeq INSIGHT℠, a comprehensive genomic and immune profiling test for solid tumors.

January 12, 2022

·

2 min read

BioMidwest

ARUP Laboratories Reduces Turnaround Time on Panel Analysis by 30% with GenomOncology

GenomOncology announced that ARUP Laboratories has chosen to extend its use of the GenomOncology Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its current workflows to strengthen its patient care offerings.

July 14, 2021

·

3 min read

BioMidwest

The Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching Capabilities by nearly 300% with GenomOncology

GenomOncology announced today that the Pancreatic Cancer Action Network (PanCAN) has chosen to upgrade to GenomOncology’s Precision Decision to further enhance the free clinical trial matching services it offers to pancreatic cancer patients.

June 9, 2021

·

3 min read